Among carbohydrates, the biocompatibility of galactose molecules and their specific recognition by galectins overexpressed in cancer cells (e.g. galectin-1 and galectin-3 [18]) have led to the development of galacto-conjugated PSs. This evidence concerns the gene LGALS1 and cancer.